Medicina

Wacker Biotech and RNAV8 Bio partner to advance mRNA-based therapies, leveraging expertise in pDNA, mRNA production, and LNP formulation. RNAV8 Bio's innovative approach to mRNA engineering optimizes untranslated regions (UTRs)…

A groundbreaking partnership between Wacker Biotech and RNAV8 Bio aims to revolutionize mRNA-based therapies in biopharma. This collaboration combines Wacker Biotech's manufacturing prowess with RNAV8 Bio's advanced mRNA engineering techniques.…